• 1. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 2. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 3. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 4. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 5. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Thiazolecarboxylic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Thiazoles Thiazolecarboxylic acids and derivatives

Comprehensive Guide to Methyl 5-bromo-2-{(tert-butoxy)carbonylamino}-1,3-thiazole-4-carboxylate (CAS No. 914349-71-6)

Methyl 5-bromo-2-{(tert-butoxy)carbonylamino}-1,3-thiazole-4-carboxylate (CAS No. 914349-71-6) is a specialized organic compound widely used in pharmaceutical research and fine chemical synthesis. This brominated thiazole derivative plays a crucial role in modern medicinal chemistry, particularly in the development of novel drug candidates. With the increasing demand for heterocyclic compounds in drug discovery, this molecule has gained significant attention from researchers and industry professionals alike.

The compound features a unique molecular structure combining a brominated thiazole core with tert-butoxycarbonyl (Boc) protection and a methyl ester functional group. This combination makes it an excellent building block for synthesizing more complex molecules. Recent trends in pharmaceutical chemistry highlight the importance of such intermediates, especially in the development of kinase inhibitors and antimicrobial agents, which are currently hot topics in drug research.

From a synthetic chemistry perspective, Methyl 5-bromo-2-{(tert-butoxy)carbonylamino}-1,3-thiazole-4-carboxylate offers several advantages. The Boc-protected amino group provides stability during synthetic transformations while allowing for selective deprotection when needed. The bromo substituent at the 5-position serves as an excellent site for further functionalization through various cross-coupling reactions, making this compound particularly valuable in combinatorial chemistry approaches.

In the context of current pharmaceutical research, this compound finds applications in several cutting-edge areas. Scientists are particularly interested in its potential for creating new antibiotic candidates, given the global concern about antimicrobial resistance. The thiazole moiety is known to exhibit various biological activities, and its modification through compounds like 914349-71-6 could lead to breakthrough medications. Additionally, the COVID-19 pandemic has increased interest in broad-spectrum antiviral agents, where such heterocyclic building blocks may play a role.

The market for pharmaceutical intermediates like Methyl 5-bromo-2-{(tert-butoxy)carbonylamino}-1,3-thiazole-4-carboxylate has been growing steadily. With pharmaceutical companies investing heavily in new drug development, the demand for high-quality, specialized building blocks continues to rise. This trend is reflected in the increasing number of scientific publications and patents mentioning this compound and its derivatives.

From a technical standpoint, researchers often search for information about the synthetic route of 914349-71-6, its purification methods, and storage conditions. The compound typically appears as a white to off-white crystalline powder and requires storage at 2-8°C in a dry environment. Its molecular weight is 333.19 g/mol, and it shows good solubility in common organic solvents like DMSO, DMF, and dichloromethane, which are important considerations for laboratory applications.

Quality control is paramount when working with Methyl 5-bromo-2-{(tert-butoxy)carbonylamino}-1,3-thiazole-4-carboxylate. Reputable suppliers provide comprehensive analytical data including HPLC purity, NMR spectra, and mass spectrometry results. Researchers should always verify these specifications, especially when the compound will be used in sensitive biological assays or as part of multi-step synthetic routes.

The future prospects for this compound appear promising. As drug discovery moves toward more targeted therapies and personalized medicine, the need for versatile building blocks like 914349-71-6 will likely increase. Its combination of protective groups, reactive sites, and heterocyclic core makes it adaptable to various medicinal chemistry strategies. Furthermore, the growing field of bioorthogonal chemistry may find applications for such carefully functionalized molecules.

For laboratories considering working with Methyl 5-bromo-2-{(tert-butoxy)carbonylamino}-1,3-thiazole-4-carboxylate, it's important to note that while the compound itself isn't classified as hazardous, standard laboratory safety protocols should always be followed. Proper personal protective equipment, including gloves and safety glasses, should be worn when handling this material, as with all laboratory chemicals.

In conclusion, Methyl 5-bromo-2-{(tert-butoxy)carbonylamino}-1,3-thiazole-4-carboxylate (CAS No. 914349-71-6) represents an important tool in modern pharmaceutical research. Its unique structural features and synthetic versatility make it valuable for medicinal chemists working on next-generation therapeutics. As the pharmaceutical industry continues to evolve, compounds like this will remain essential for developing innovative solutions to global health challenges.

• 914347-09-4(N-Boc-2-Amino-5-bromothiazole-4-carboxylic acid)
• 850429-62-8(N-Boc Methyl 2-Aminothioazole-4-carboxylate)
• 83673-98-7(2-Boc-aminothiazole-4-carboxylic acid)
• 61830-21-5(Ethyl 2-amino-5-bromothiazole-4-carboxylate)
• 947179-42-2(tert-Butyl (5-bromo-4-methylthiazol-2-yl)carbamate)
• 1279863-32-9(ethyl 5-bromo-2-{(tert-butoxy)carbonylamino}-1,3-thiazole-4-carboxylate)
• 2580233-13-0(2-{(benzyloxy)carbonylamino}-5-bromo-1,3-thiazole-4-carboxylic acid)
• 128014-67-5(4-Thiazolecarboxylic acid, 2-(acetylamino)-5-bromo-, ethyl ester)
• 2680714-99-0(ethyl 2-{(benzyloxy)carbonylamino}-5-bromo-1,3-thiazole-4-carboxylate)
• 189512-01-4(Ethyl 2-(Tert-butoxycarbonyl)amino-1,3-thiazole-4-carboxylate)